معرفی
Eric Wahlberg serves as an Adjunct Professor at Linköping University's Faculty of Medicine, primarily affiliated with the Department of Health, Medicine and Care (HMV), with secondary ties to the Department of Diagnostics and Specialist Medicine (DISP). With over 40 years of cross-sector experience spanning clinical practice, healthcare administration, and global pharmaceutical leadership—including executive roles at Novartis and AstraZeneca—he bridges academic research with industry innovation in life sciences.
His educational foundation includes:
- Medical Degree, Karolinska Institutet
- MBA, Stockholm School of Economics
Wahlberg's research centers on vascular surgery and peripheral arterial disease, extending into health economics, healthcare governance, and biomedical technology innovation. His work integrates clinical epidemiology with preventive strategies, focusing on cardiovascular risk stratification through ankle artery diagnostics and lifestyle interventions. He actively mentors life science startups via the Novo Nordisk Foundation Mentor Network (NOME), advising on commercialization of university research.
Analysis of his 2018-2024 publications reveals consistent emphasis on population-based studies of peripheral arterial disease progression, cardiovascular risk prediction, and long-term outcomes. His research demonstrates methodological evolution from mortality analysis (2018) toward refined risk stratification tools (2024), highlighting clinical translation of epidemiological data for preventive cardiology.
As an educator, Wahlberg teaches vascular surgery, epidemiology, and healthcare leadership at undergraduate levels and to clinical professionals. He supervises doctoral students while serving on boards of Nordic life science startups, leveraging his dual expertise in clinical medicine and business development to translate research into operational healthcare solutions.
His collaborative network spans Karolinska Institutet, Uppsala University, and the Cardiovascular Sciences Unit (KAV) at Linköping, with active participation in clinical-translational research through Forum Östergötland.
